Literature DB >> 23770163

Chagas disease: an overview of clinical and epidemiological aspects.

Maria Carmo Pereira Nunes1, Wistremundo Dones, Carlos A Morillo, Juan Justiniano Encina, Antônio Luiz Ribeiro.   

Abstract

Chagas disease, caused by the parasite Trypanosoma cruzi, is a serious health problem in Latin America and is an emerging disease in non-endemic countries. In recent decades, the epidemiological profile of the disease has changed due to new patterns of immigration and successful control in its transmission, leading to the urbanization and globalization of the disease. Dilated cardiomyopathy is the most important and severe manifestation of human chronic Chagas disease and is characterized by heart failure, ventricular arrhythmias, heart blocks, thromboembolic phenomena, and sudden death. This article will present an overview of the clinical and epidemiological aspects of Chagas disease. It will focus on several clinical aspects of the disease, such as chronic Chagas disease without detectable cardiac pathology, as well as dysautonomia, some specific features, and the principles of treatment of chronic cardiomyopathy.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ChD; Chagas disease; E/e'; ECG; ICD; LV; VT; dilated cardiomyopathy; early transmitral flow velocity to the early diastolic velocity of the mitral annulus; electrocardiogram; heart failure; implantable cardioverter-defibrillator; left ventricle/ventricular; ventricular tachycardia

Mesh:

Year:  2013        PMID: 23770163     DOI: 10.1016/j.jacc.2013.05.046

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  107 in total

1.  An Aromatic Diamidine That Targets Kinetoplast DNA, Impairs the Cell Cycle in Trypanosoma cruzi, and Diminishes Trypomastigote Release from Infected Mammalian Host Cells.

Authors:  Richard M B M Girard; Marcell Crispim; Ivana Stolić; Flávia Silva Damasceno; Marcelo Santos da Silva; Eizabeth Mieko Furusho Pral; Maria Carolina Elias; Miroslav Bajić; Ariel Mariano Silber
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Identification of novel Trypanosoma cruzi prolyl oligopeptidase inhibitors by structure-based virtual screening.

Authors:  Hugo de Almeida; Vincent Leroux; Flávia Nader Motta; Philippe Grellier; Bernard Maigret; Jaime M Santana; Izabela Marques Dourado Bastos
Journal:  J Comput Aided Mol Des       Date:  2016-10-21       Impact factor: 3.686

3.  Arrhythmogenic right ventricular cardiomyopathy in a weimaraner.

Authors:  Bryan D Eason; Stacey B Leach; Keiichi Kuroki
Journal:  Can Vet J       Date:  2015-10       Impact factor: 1.008

Review 4.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  AKT network of genes and impaired myocardial contractility during murine acute Chagasic myocarditis.

Authors:  Andrés F Henao-Martínez; Anne Hermetet Agler; Alan M Watson; Corinne Hennessy; Elizabeth Davidson; Kim Demos-Davies; Timothy A McKinsey; Michael Wilson; David A Schwartz; Ivana V Yang
Journal:  Am J Trop Med Hyg       Date:  2015-01-12       Impact factor: 2.345

6.  Ventricular arrhythmias in chronic Chagas cardiomyopathy: Can studying myocardial sympathetic denervation provide the answers?

Authors:  Vineet Kumar
Journal:  J Nucl Cardiol       Date:  2016-07-12       Impact factor: 5.952

7.  The detection of Trypanosoma cruzi by nested-PCR in elderly patients: relationship to the clinical and epidemiological profile.

Authors:  Mariane Barroso Pereira; Angélica Martins Batista; Camila Aguiar; Glaucia Elisete Barbosa Marcon; Luiz Cláudio Martins; Maria Elena Guariento; Sandra Cecília Botelho Costa; Eros Antonio de Almeida
Journal:  Pathog Glob Health       Date:  2016-09-26       Impact factor: 2.894

8.  Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy.

Authors:  Denise Mayumi Tanaka; Luciano Fonseca Lemos de Oliveira; José Antônio Marin-Neto; Minna Moreira Dias Romano; Eduardo Elias Vieira de Carvalho; Antonio Carlos Leite de Barros Filho; Fernando Fonseca França Ribeiro; Jorge Mejia Cabeza; Carla Duque Lopes; Camila Godoy Fabricio; Norival Kesper; Henrique Turin Moreira; Lauro Wichert-Ana; André Schmidt; Maria de Lourdes Higuchi; Edécio Cunha-Neto; Marcus Vinícius Simões
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

9.  Chagasic cardiomyopathy and Pompe disease: case report.

Authors:  Rafael Ob de Morais; Ândrea V Chaves-Markman; Anna Pp Miranda; Ingrid G Amorim; Maria da Ga de M Cavalcanti; Manuel Markman; Brivaldo Markman-Filho
Journal:  Am J Cardiovasc Dis       Date:  2018-04-05

10.  Chagas Cardiomyopathy in New Orleans and the Southeastern United States.

Authors:  Robert C Hsu; Joshua Burak; Sumit Tiwari; Chayan Chakraborti; Gary E Sander
Journal:  Ochsner J       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.